SNWV Overview

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

Wall Street analysts forecast SNWV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNWV is54.00 USD with a low forecast of 53.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

SANUWAVE Health Inc revenue for the last quarter amounts to 9.62M USD, increased 2.97

SANUWAVE Health Inc. EPS for the last quarter amounts to -0.17 USD, decreased -74.24

SANUWAVE Health Inc (SNWV) has 55 emplpoyees as of May 14 2026.

Today SNWV has the market capitalization of 137.92M USD.